Qsymia (15mg phentermine/92mg topiramate) is the highest-strength, once-daily extended-release capsule for chronic weight management, used with reduced calories and exercise in adults (BMI \(\ge \) 30 or \(\ge \) 27 with comorbidity) and adolescents (12+). It suppresses appetite and increases satiety, with 12-week assessments typically guiding dosage, aiming for \(>5\%\) weight loss.
